Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIRT 2584 XX DDI with Midazolam in Healthy Volunteers
NCT02256748Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2005
- Primary completion
- Aug 2005
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of BIRT 2584 XX in psoriasis and multiple sclerosis (MS), sponsored by Boehringer Ingelheim. Primary endpoints: Area Under the Concentration-Time Curve from 0 to Infinity up to 13 days, Maximum Plasma Concentration up to 13 days and 1 more. Started Jun 2005; status: completed.
02
Drugs
BIRT 2584 XX
03
Conditions
psoriasismultiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02256748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256748.